Trial Outcomes & Findings for Just Kwit: Mobile Intervention for Tobacco Cessation (NCT NCT03538678)
NCT ID: NCT03538678
Last Updated: 2021-02-18
Results Overview
Assessment of feasibility - Descriptive statistics that will be obtained via a follow up survey will be used to assess feasibility. The follow up survey will be administered one month after discharge via email, phone or in-person, determined by the preference of the participant. Specific questions will be asked asking participants to rate the Kwit smartphone application based on helpfulness, ease of use, and to list frustrations and helpful aspects of the application. How helpful was the Kwit app? Very helpful Somewhat helpful Neutral Not very helpful Not at all helpful Was the app easy to use? Very Somewhat Neutral Not much Not at all Was it frustrating to use? Very Somewhat Neutral Not much Not at all What, if anything, was helpful about the app? What, if anything, was not helpful about the app?
COMPLETED
NA
40 participants
1-month
2021-02-18
Participant Flow
Participant milestones
| Measure |
Kwit App
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
Patient initiated follow-up post discharge
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
5
|
9
|
|
Overall Study
NOT COMPLETED
|
15
|
11
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Just Kwit: Mobile Intervention for Tobacco Cessation
Baseline characteristics by cohort
| Measure |
Kwit App
n=20 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
n=20 Participants
Patient initiated follow-up post discharge
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
<18
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
>=18 and <=30
|
20 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Age, Customized
>30
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
20 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
13 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=5 Participants
|
20 participants
n=7 Participants
|
40 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1-monthPopulation: Only applicable for experimental arm
Assessment of feasibility - Descriptive statistics that will be obtained via a follow up survey will be used to assess feasibility. The follow up survey will be administered one month after discharge via email, phone or in-person, determined by the preference of the participant. Specific questions will be asked asking participants to rate the Kwit smartphone application based on helpfulness, ease of use, and to list frustrations and helpful aspects of the application. How helpful was the Kwit app? Very helpful Somewhat helpful Neutral Not very helpful Not at all helpful Was the app easy to use? Very Somewhat Neutral Not much Not at all Was it frustrating to use? Very Somewhat Neutral Not much Not at all What, if anything, was helpful about the app? What, if anything, was not helpful about the app?
Outcome measures
| Measure |
Kwit App
n=5 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
Patient initiated follow-up post discharge
|
|---|---|---|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App helpful · Very
|
2 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App helpful · Somewhat
|
2 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App helpful · Neutral
|
1 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App helpful · Not very
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App helpful · Not at all
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App easy to use · Very
|
3 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App easy to use · Somewhat
|
2 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App easy to use · Neutral
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App easy to use · Not very
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App easy to use · Not at all
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App frustrating to use · Very
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App frustrating to use · Somewhat
|
1 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App frustrating to use · Neutral
|
0 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App frustrating to use · Not very
|
2 Participants
|
—
|
|
Feasibility - Helpfulness and Ease of Use of the Intervention Smartphone App
App frustrating to use · Not at all
|
2 Participants
|
—
|
PRIMARY outcome
Timeframe: 1-monthPopulation: Only applicable for experimental arm
Assessment of feasibility - Descriptive statistics that will be obtained via a follow up survey will be used to assess feasibility. The follow up survey will be administered one month after discharge via email, phone or in-person, determined by the preference of the participant. Specific questions will be asked asking participants to rate the Kwit smartphone application based on frequency of use.
Outcome measures
| Measure |
Kwit App
n=5 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
Patient initiated follow-up post discharge
|
|---|---|---|
|
Feasibility - Frequency of Use
Almost everyday
|
0 Participants
|
—
|
|
Feasibility - Frequency of Use
Several days/week
|
2 Participants
|
—
|
|
Feasibility - Frequency of Use
Several days/month
|
3 Participants
|
—
|
|
Feasibility - Frequency of Use
Not at all
|
0 Participants
|
—
|
SECONDARY outcome
Timeframe: 1-monthAssessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. Since you left the hospital in (month/year), have you smoked a cigarette (even a puff)? In the past 30 days, have you smoked a cigarette, even a puff? In the past 7 days, have you smoked a cigarette, even a puff?
Outcome measures
| Measure |
Kwit App
n=5 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
n=9 Participants
Patient initiated follow-up post discharge
|
|---|---|---|
|
Cessation--point Prevalence Abstinence
Smoke since leaving hospital · Yes
|
4 Participants
|
8 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke since leaving hospital · No
|
1 Participants
|
1 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke since leaving hospital · Don't know
|
0 Participants
|
0 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke since leaving hospital · Did not answer
|
0 Participants
|
0 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 30 days · Yes
|
3 Participants
|
8 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 30 days · No
|
0 Participants
|
0 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 30 days · Don't know
|
1 Participants
|
0 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 30 days · Did not answer
|
1 Participants
|
1 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 7 days · Yes
|
4 Participants
|
5 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 7 days · No
|
0 Participants
|
3 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 7 days · Don't know
|
0 Participants
|
0 Participants
|
|
Cessation--point Prevalence Abstinence
Smoke past 7 days · Did not answer
|
1 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: 1-monthPopulation: 4 participants (2 exp, 2 control) did not answer this question.
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. (On the days you smoked), how many cigarettes on average did you smoke (even a puff)?
Outcome measures
| Measure |
Kwit App
n=3 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
n=7 Participants
Patient initiated follow-up post discharge
|
|---|---|---|
|
Cessation--cigarettes Smoked
|
4.67 Cigarettes smoked
Standard Deviation 0.58
|
8.14 Cigarettes smoked
Standard Deviation 5.49
|
SECONDARY outcome
Timeframe: 1-monthPopulation: 5 participants (2 exp, 3 control) did not answer this question.
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. In the past 30 days, on how many days did you smoke (even a puff)?
Outcome measures
| Measure |
Kwit App
n=3 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
n=6 Participants
Patient initiated follow-up post discharge
|
|---|---|---|
|
Cessation--days Smoked
|
21.67 Days
Standard Deviation 7.64
|
17.67 Days
Standard Deviation 12.97
|
SECONDARY outcome
Timeframe: 1-monthPopulation: 2 participants (1 exp, 1 control) did not answer this question.
Assessment of cessation - Descriptive statistics will be used to assess cessation outcomes. The information will be obtained via a follow up survey with specific questions pertaining to the level of participant smoking as well as their confidence levels on maintaining cessation. How confident are you that you will be able to stay quit?
Outcome measures
| Measure |
Kwit App
n=4 Participants
Use of Kwit smartphone app
Kwit smartphone app: Kwit smarphone app
|
Standard of Care
n=8 Participants
Patient initiated follow-up post discharge
|
|---|---|---|
|
Cessation--confidence
Not at all confident
|
1 Participants
|
1 Participants
|
|
Cessation--confidence
A little confident
|
0 Participants
|
0 Participants
|
|
Cessation--confidence
Somewhat confident
|
1 Participants
|
3 Participants
|
|
Cessation--confidence
Fairly confident
|
1 Participants
|
2 Participants
|
|
Cessation--confidence
Very confident
|
1 Participants
|
1 Participants
|
|
Cessation--confidence
Don't know
|
0 Participants
|
0 Participants
|
|
Cessation--confidence
Refuse to answer
|
0 Participants
|
0 Participants
|
|
Cessation--confidence
N/A
|
0 Participants
|
1 Participants
|
Adverse Events
Kwit App
Standard of Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place